Security key
40637H109
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)
CUSIP: 40637H109
Q2 2017 13F Holders as of 30 Jun 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 118,494,184
- Total 13F shares
- 121,956,653
- Share change
- +6,878,167
- Total reported value
- $1,561,931,486
- Put/Call ratio
- 12%
- Price per share
- $12.82
- Number of holders
- 164
- Value change
- +$88,012,978
- Number of buys
- 99
- Number of sells
- 54
Report period
Q2 2017
Institutions
164
Top holders
10
HALO full security history
Newer quarter: Q3 2017
Previous quarter: Q1 2017
HALOZYME THERAPEUTICS, INC. SEC filings
HALOZYME THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 40637H109
Recent filing periods:
Top shareholders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Third Security, LLC |
13F
|
Company |
16%
|
19,305,403
|
$250,198,000 | — | 31 Mar 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9.3%
|
11,062,842
|
$143,374,000 | — | 31 Mar 2017 | |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
|
Company |
8.8%
|
10,400,388
|
$134,789,000 | — | 31 Mar 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.4%
|
8,763,558
|
$113,576,000 | — | 31 Mar 2017 | |
| BB BIOTECH AG |
13F
|
Company |
6.5%
|
7,749,832
|
$100,438,000 | — | 31 Mar 2017 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
6.2%
|
7,394,315
|
$95,830,000 | — | 31 Mar 2017 | |
| FMR LLC |
13F
|
Company |
5.1%
|
6,096,781
|
$79,014,000 | — | 31 Mar 2017 | |
| Invesco Ltd. |
13F
|
Company |
3.8%
|
4,484,611
|
$58,121,000 | — | 31 Mar 2017 | |
| STATE STREET CORP |
13F
|
Company |
3.1%
|
3,614,672
|
$46,842,000 | — | 31 Mar 2017 | |
| SENZAR ASSET MANAGEMENT, LLC |
13F
|
Company |
2.9%
|
3,489,864
|
$45,229,000 | — | 31 Mar 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.5%
|
2,915,415
|
$37,784,000 | — | 31 Mar 2017 | |
| SNYDER CAPITAL MANAGEMENT L P |
13F
|
Company |
2%
|
2,318,433
|
$30,047,000 | — | 31 Mar 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.5%
|
1,806,490
|
$23,412,000 | — | 31 Mar 2017 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,551,283
|
$20,105,000 | — | 31 Mar 2017 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
1.2%
|
1,457,426
|
$18,888,000 | — | 31 Mar 2017 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.2%
|
1,391,507
|
$18,034,000 | — | 31 Mar 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
1,385,414
|
$17,955,000 | — | 31 Mar 2017 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.87%
|
1,035,837
|
$13,424,000 | — | 31 Mar 2017 | |
| NORGES BANK |
13F
|
Company |
0.86%
|
1,014,852
|
$13,153,000 | — | 31 Mar 2017 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.85%
|
1,002,176
|
$12,988,000 | — | 31 Mar 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.81%
|
962,500
|
$12,473,000 | — | 31 Mar 2017 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.74%
|
880,358
|
$11,409,000 | — | 31 Mar 2017 | |
| MSD Partners, L.P. |
13F
|
Company |
0.65%
|
765,000
|
$9,914,000 | — | 31 Mar 2017 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.59%
|
696,445
|
$9,026,000 | — | 31 Mar 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.57%
|
678,108
|
$8,788,000 | — | 31 Mar 2017 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.52%
|
616,511
|
$7,990,000 | — | 31 Mar 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.43%
|
511,460
|
$6,628,000 | — | 31 Mar 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.42%
|
500,613
|
$6,488,000 | — | 31 Mar 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.39%
|
465,766
|
$6,037,000 | — | 31 Mar 2017 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.39%
|
460,000
|
$5,962,000 | — | 31 Mar 2017 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.35%
|
414,611
|
$5,373,000 | — | 31 Mar 2017 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.31%
|
364,014
|
$4,718,000 | — | 31 Mar 2017 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.3%
|
358,000
|
$4,636,000 | — | 31 Mar 2017 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.26%
|
309,725
|
$4,014,000 | — | 31 Mar 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.26%
|
303,626
|
$3,935,000 | — | 31 Mar 2017 | |
| Lombard Odier Asset Management (Switzerland) SA |
13F
|
Company |
0.25%
|
300,000
|
$3,888,000 | — | 31 Mar 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.25%
|
295,613
|
$3,831,000 | — | 31 Mar 2017 | |
| Bellevue Group AG |
13F
|
Company |
0.23%
|
270,000
|
$3,499,000 | — | 31 Mar 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.22%
|
261,336
|
$3,386,000 | — | 31 Mar 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.21%
|
247,828
|
$3,210,000 | — | 31 Mar 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.2%
|
239,687
|
$3,106,000 | — | 31 Mar 2017 | |
| S.c.a. Candriam |
13F
|
Individual |
0.18%
|
217,000
|
$2,812,000 | — | 31 Mar 2017 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.18%
|
214,738
|
$2,783,000 | — | 31 Mar 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.18%
|
210,027
|
$2,722,000 | — | 31 Mar 2017 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.17%
|
200,000
|
$2,592,000 | — | 31 Mar 2017 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.17%
|
198,838
|
$2,577,000 | — | 31 Mar 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.16%
|
190,502
|
$2,469,000 | — | 31 Mar 2017 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.16%
|
190,300
|
$2,466,000 | — | 31 Mar 2017 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.16%
|
184,124
|
$2,385,000 | — | 31 Mar 2017 | |
| Swiss National Bank |
13F
|
Company |
0.15%
|
180,500
|
$2,339,000 | — | 31 Mar 2017 |
Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q2 2017
As of 30 Jun 2017,
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
121,956,653 shares.
The largest 10 holders included
Third Security, LLC, BlackRock Inc., IRIDIAN ASSET MANAGEMENT LLC/CT, VANGUARD GROUP INC, BB BIOTECH AG, First Eagle Investment Management, LLC, FMR LLC, Invesco Ltd., SENZAR ASSET MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
164
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
155
Q2 2017 holders
164
Holder diff
9
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.